Given the limitations of current therapies including nucleos(t)ide analogues and pegylated interferon alpha, novel agents targeting functional cure are emerging
Patients burned by coverage denials and mid-year formulary changes are no longer assuming that insurance is the only legitimate way to pay for care
The peptide program is detailed on the advanced peptide therapy page
[PMID: 42390457] PubMed record related to this compound for laboratory literature review
Arch Toxicol 96(7):20212032 Miaris N, Zezas S, Sgouros J, Zirou DC, Gkoura S, Stamoulis G, Angelopoulou H, Avgeropoulos G, Samantas E (2017) Effective use of levosimendan in anthracycline-induced cardiomyopathy: a case report
If you are on tirzepatide at 5 mg or 7.5 mg and feeling like it is not working, the answer is almost certainly dose optimization rather than adding a second medication